跳到正文
原文
Eric Topol· @EricTopol · X·· 1 天前AI 评分42
AI 导读

JAMA Neurology发表两项阿尔茨海默病生物标志物研究:一项随机试验显示,用数字化沟通方式告知APOE4与p-tau217检测结果不劣于临床医生远程医疗告知,且更具可扩展性。另一项数据显示,过去18个月美国p-tau17检测量增长超过7倍。

正文

2 new studies on Alzheimer's biomarkers @JAMANeuro
—A randomized trial of digital communication vs clinician telehealth for results of APOE4 and p-tau217 support use of the former with non-inferiority and scalability
https://jamanetwork.com/journals/jamaneurology/fullarticle/2856813?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jamaneurol.2026.4279
—In the past 18 months, p-tau17 testing went up over 7-fold in the United States https://jamanetwork.com/journals/jama/fullarticle/2856893?utm_campaign=articlePDF&utm_medium=articlePDFlink&utm_source=articlePDF&utm_content=jama.2026.23534

来源:Eric Topol · x.com